dobutamine has been researched along with tetradecanoylphorbol acetate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bross, T; Geiger, KK; Hoetzel, A; Humar, M; Loop, T; Pahl, HL; Pannen, BHJ; Schmidt, R | 1 |
| Nakamura, J | 2 |
3 other study(ies) available for dobutamine and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Dobutamine inhibits phorbol-myristate-acetate-induced activation of nuclear factor-kappaB in human T lymphocytes in vitro.
Topics: Adrenergic Agents; Adrenergic beta-Agonists; Anti-Inflammatory Agents; CD3 Complex; Cell Nucleus; Clenbuterol; DNA; Dobutamine; Electrophoretic Mobility Shift Assay; Humans; Jurkat Cells; NF-kappa B; Receptors, Adrenergic, alpha; T-Lymphocytes; Tetradecanoylphorbol Acetate; Xamoterol | 2004 |
Protein kinase C-dependent antilipolysis by insulin in rat adipocytes.
Topics: Adipocytes; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Androstadienes; Angiotensin II; Animals; Carbazoles; Carcinogens; Dobutamine; Enzyme Activation; Enzyme Inhibitors; Glycerol; Imidazoles; Indoles; Insulin; Isoenzymes; Lipolysis; Male; Maleimides; Protein Kinase C; Rats; Receptor, Insulin; Tetradecanoylphorbol Acetate; Wortmannin | 2007 |
Protein kinase CbetaI interacts with the beta1-adrenergic signaling pathway to attenuate lipolysis in rat adipocytes.
Topics: Adipocytes; Adrenergic beta-Agonists; Animals; Dobutamine; Fasting; Isoenzymes; Lipolysis; Protein Kinase C; Protein Kinase C beta; Rats; Receptors, Adrenergic, beta-1; Signal Transduction; Tetradecanoylphorbol Acetate | 2008 |